Key statistics
On Friday, Twist Bioscience Corp (0ME:STU) closed at 41.71, -22.90% below its 52-week high of 54.10, set on Jul 16, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 42.39 |
---|---|
High | 42.39 |
Low | 41.71 |
Bid | 41.74 |
Offer | 42.45 |
Previous close | 42.70 |
Average volume | 4.40 |
---|---|
Shares outstanding | 58.59m |
Free float | 57.58m |
P/E (TTM) | -- |
Market cap | 2.72bn USD |
EPS (TTM) | -3.81 USD |
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Press releases
- Twist Bioscience Achieves LEED Certification for Sustainable Operations and Maintenance
- Twist Bioscience Releases 2024 Corporate Responsibility Report and Quantifies Carbon Footprint of Oligo Manufacturing Process for NGS Target Enrichment Panels
- Twist Bioscience to Present at Baird Global Healthcare Conference 2024
- Twist Bioscience Expands Gene Offering With Long Gene Fragments up to 5.0kb
- Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
- Twist Bioscience and bitBiome Announce Strategic Collaboration and First Offering to Deliver One-of-a-Kind Enzymes for Biocatalysis
- Twist Bioscience Reports Fiscal Third Quarter 2024 Financial Results
- Twist Bioscience Announces Clinical Progression of Pure Biologics’ Antibody Candidate Discovered Using Twist’s Antibody Libraries
- Twist Bioscience to Report Fiscal 2024 Third Quarter Financial Results on Friday, August 2, 2024
- Twist Bioscience Expands High-Throughput IgG Antibody Portfolio with Launch of CHO Express Antibodies
More ▼